Literature DB >> 22065492

Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer.

Xiao-Yuan Chu1, Long-Bang Chen, Jing-Hua Wang, Quan-Sheng Su, Ji-Rong Yang, Yong Lin, Li-Jun Xue, Xiao-Bei Liu, Xiao-Bei Mo.   

Abstract

BACKGROUND: The aim of this study was to investigate the association of survivin expression with metastasis of colorectal cancer (CRC).
METHODS: RT-PCR and Western blot assays were performed to detect survivin expression in CRC cells and normal intestinal epithelial cell. The expression of survivin gene was also detected in 15 CRC tissues, surrounding and adjacent colon tissues. Moreover, survivin expression in 48 CRC tissues with or without lymph node metastasis was analyzed. Multivariate analysis for lymph node metastasis was performed using logistic regression model. RNA interference was used to inhibit survivin expression in CRC cells and analyze its effect on invasion and metastasis of CRC cells.
RESULTS: The expression levels of survivin mRNA and protein were higher in CRC cells than in normal intestinal epithelial cell line. The average levels of survivin mRNA and protein were higher in CRC tissues than surrounding or adjacent colon tissues (P < 0.05). High survivin expression was an independent factor for predicting lymph node metastasis of CRC (P = 0.043). RNAi-mediated survivin knockdown could significantly inhibit in vitro invasion and in vivo metastasis of CRC cells, which might be inactivation of matrix metalloproteinases.
CONCLUSION: Targeting survivin will be a potential strategy to suppress metastasis of CRC.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22065492     DOI: 10.1002/jso.22134

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  25 in total

1.  Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

Authors:  Xu Wang; Jonathan J Beitler; Wen Huang; Guo Chen; Guoqing Qian; Kelly Magliocca; Mihir R Patel; Amy Y Chen; Jun Zhang; Sreenivas Nannapaneni; Sungjin Kim; Zhengjia Chen; Xingming Deng; Nabil F Saba; Zhuo Georgia Chen; Jack L Arbiser; Dong M Shin
Journal:  Clin Cancer Res       Date:  2017-11-27       Impact factor: 12.531

2.  Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.

Authors:  Chengfei Liu; Wei Lou; Cameron Armstrong; Yezi Zhu; Christopher P Evans; Allen C Gao
Journal:  Prostate       Date:  2015-05-13       Impact factor: 4.104

3.  MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.

Authors:  Jocelyn F Burke; Logan Schlosser; April D Harrison; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2013-07-31       Impact factor: 5.344

4.  Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients.

Authors:  Katarzyna Jakubowska; Anna Pryczynicz; Violetta Dymicka-Piekarska; Waldemar Famulski; Katarzyna Guzińska-Ustymowicz
Journal:  Oncol Lett       Date:  2016-09-01       Impact factor: 2.967

Review 5.  Androgen receptor variation affects prostate cancer progression and drug resistance.

Authors:  Edel McCrea; Tristan M Sissung; Douglas K Price; Cindy H Chau; William D Figg
Journal:  Pharmacol Res       Date:  2016-10-07       Impact factor: 7.658

6.  Expression of survivin and its four splice variants in colorectal cancer and its clinical significances.

Authors:  Quan-Xing Ge; Yu-Yuan Li; Yu-Qiang Nie; Wen-Ge Zuo; Yan-Lei Du
Journal:  Med Oncol       Date:  2013-03-15       Impact factor: 3.064

7.  Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.

Authors:  Yan Ning; Diana L Hanna; Wu Zhang; Angela Mendez; Dongyun Yang; Rita El-Khoueiry; Satoshi Matsusaka; Yu Sunakawa; Stefan Stremitzer; Anish Parekh; Satoshi Okazaki; Martin D Berger; Afsaneh Barzi; Heinz-Josef Lenz
Journal:  Mol Cancer Ther       Date:  2015-07-30       Impact factor: 6.261

8.  Survivin promotion of melanoma metastasis requires upregulation of α5 integrin.

Authors:  Jodi A McKenzie; Tong Liu; Jae Y Jung; Benjamin B Jones; Huseyin A Ekiz; Alana L Welm; Douglas Grossman
Journal:  Carcinogenesis       Date:  2013-05-02       Impact factor: 4.944

9.  A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.

Authors:  Xiang Ling; Shousong Cao; Qiuying Cheng; James T Keefe; Youcef M Rustum; Fengzhi Li
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

10.  High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.

Authors:  Ingeborg Fraunholz; Claus Rödel; Luitpold Distel; Marget Rave-Fränk; Daniela Kohler; Stefan Falk; Franz Rödel
Journal:  Radiat Oncol       Date:  2012-06-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.